Barely Significant
← all excerpts

Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study.

J Am Heart Assoc · 2023 · PMC10122907 · PMID 36942759

Europe PMCDOI
1
hedged sentence
0.0620
closest p · 1.2× alpha
0.0620
boldest claim

The sentences

borderline significantP =0.062so close (0.05 < p ≤ 0.1)
A Portuguese study from 2018 on 30 patients with BrS and an ICD implanted found that 53.3% of the included patients had taken a nonrecommended drug, and that 6 out of 7 patients (85.7%) who had experienced appropriate ICD therapies had received a nonrecommended drug as opposed to 45.4% of patients without ICD therapies (difference borderline significant, P =0.062). 4 The authors found a mean time between therapies and unsafe drug use of 3.8±7.5 days.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.